Search results
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 5 days agoThe FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 7 days agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
FDA delays decision date for Moderna's RSV vaccine - Boston Business Journal
The Business Journals· 5 days agoJust days before its deadline, the U.S. Food and Drug Administration says it's giving itself more...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 5 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters· 5 days ago, opens new tab respiratory syncytial virus (RSV) vaccine due to "administrative constraints" and...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 5 days agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 5 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...